Taejon, South Korea

Hyung Cheol Kim


Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Yusung-ku, KR (1997)
  • Taejon, KR (1997 - 1999)

Company Filing History:


Years Active: 1997-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Hyung Cheol Kim

Introduction

Hyung Cheol Kim is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating central nervous system disorders. With a total of four patents to his name, Kim's work is recognized for its potential therapeutic applications.

Latest Patents

One of his latest patents is focused on sulfamate compounds containing N-substituted carbamoyl groups. These compounds, including their racemates and optical isomers, are pharmaceutically useful for the prophylaxis and treatment of various disorders, such as nervous myalgia, epilepsy, and minimal brain dysfunction. Another patent involves carbamate compounds and the processes for preparing them, showcasing his innovative approach to pharmaceutical chemistry.

Career Highlights

Hyung Cheol Kim is currently associated with Yukong Limited, where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but also holds promise for improving patient outcomes in neurology.

Collaborations

Throughout his career, Kim has collaborated with esteemed colleagues, including Yong Moon Choi and Dong Il Han. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Hyung Cheol Kim's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of central nervous system disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…